Michael Ernste is a seasoned professional in the field of radiochemistry, currently serving as the Director of Translational Radiochemistry at Eli Lilly and Company. With a Bachelor of Science in Chemistry from McMaster University, Michael has held various roles throughout their career, including Method Development Chemist at Apotex Inc. and Analytical Scientist at the Center for Probe Development and Commercialization. Michael's expertise extends to developing analytical methods for radiopharmaceuticals and ensuring regulatory compliance in their work. Prior to their current position, Michael was a Senior Manager of Translational Radiochemistry at POINT Biopharma and an R&D Scientist at SGS Life Science Services.
This person is not in the org chart
This person is not in any teams
This person is not in any offices